Leonidas E Bantis
Overview
Explore the profile of Leonidas E Bantis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
807
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schieber T, Brunk K, Clennon A, Woolbright B, Bantis L, Grauer D, et al.
Exp Hematol Oncol
. 2025 Mar;
14(1):36.
PMID: 40075416
Penile squamous cell carcinoma (PSCC) is a rare malignancy, and first-line therapy typically involves cisplatin-based chemotherapy. However, these regimens are often unsuitable for patients with poor performance status or advanced...
2.
Bantis L, Brewer B, Nakas C, Reiser B
Stat Med
. 2024 Nov;
43(30):6099-6122.
PMID: 39551723
Receiver operating characteristic (ROC) curve analysis is widely used in evaluating the effectiveness of a diagnostic test/biomarker or classifier score. A parametric approach for statistical inference on ROC curves based...
3.
Young K, Bantis L
Stat Methods Med Res
. 2024 Aug;
33(9):1577-1594.
PMID: 39118330
measures of biomarker accuracy that employ the receiver operating characteristic surface have been proposed for biomarkers that classify patients into one of three groups: healthy, benign, or aggressive disease. The...
4.
Baird C, Wulff-Burchfield E, Egan P, Hugar L, Vyas A, Trikalinos N, et al.
J Geriatr Oncol
. 2024 Apr;
15(5):101774.
PMID: 38676975
Introduction: High-intensity end-of-life (EoL) care can be burdensome for patients, caregivers, and health systems and does not confer any meaningful clinical benefit. Yet, there are significant knowledge gaps regarding the...
5.
Mosier B, Bantis L
Stat Methods Med Res
. 2024 Mar;
33(4):647-668.
PMID: 38445348
The performance of individual biomarkers in discriminating between two groups, typically the healthy and the diseased, may be limited. Thus, there is interest in developing statistical methodologies for biomarker combinations...
6.
Tai M, Bantis L, Parhy G, Kato T, Tanaka I, Chow C, et al.
Int J Mol Sci
. 2024 Feb;
25(4).
PMID: 38397007
Early-stage lung adenocarcinoma (LUAD) patients remain at substantial risk for recurrence and disease-related death, highlighting the unmet need of biomarkers for the assessment and identification of those in an early...
7.
Brewer B, Bantis L
Stat Med
. 2023 Dec;
43(3):606-623.
PMID: 38038216
Tuberculosis (TB) studies often involve four different states under consideration, namely, "healthy," "latent infection," "pulmonary active disease," and "extra-pulmonary active disease." While highly accurate clinical diagnosis tests do exist, they...
8.
Trinidad C, Pathak H, Cheng S, Tzeng S, Madan R, Sardiu M, et al.
Sci Rep
. 2023 Oct;
13(1):18341.
PMID: 37884576
High grade serous ovarian carcinoma (HGSOC) accounts for ~ 70% of ovarian cancer cases. Non-invasive, highly specific blood-based tests for pre-symptomatic screening in women are crucial to reducing the mortality...
9.
Turaga S, Sardiu M, Vishwakarma V, Mitra A, Bantis L, Madan R, et al.
Front Mol Biosci
. 2023 May;
10:1138594.
PMID: 37122563
Ewing Sarcoma (EWS) is the second most common osseous malignancy in children and young adults after osteosarcoma, while it is the fifth common osseous malignancy within adult age population. The...
10.
Zha D, Rayamajhi S, Sipes J, Russo A, Pathak H, Li K, et al.
Bioengineering (Basel)
. 2023 Apr;
10(4).
PMID: 37106610
The human fallopian tube epithelium (hFTE) is the site of fertilization, early embryo development, and the origin of most high-grade serous ovarian cancers (HGSOCs). Little is known about the content...